At Cellistic, iPSC scale-up isn’t a flavor-of-the-day. It’s a first language. It’s a promise waiting to be kept. It’s how the next generation of allogeneic cell therapy innovators will improve patients’ lives everywhere. And it’s all driven here by a team with deep, diverse expertise in the business and science of cell therapy.  

Gustavo Mahler, PhD

Chief Executive Officer

Stefan Braam, PhD

Chief Technical Officer

Jonas Mortensen

Chief Commercial Officer

Charles Jacques

Chief Financial Officer

Astrid Norenberg, PhD

Head of Project Management

Teaming up with Cellistic

Your best science deserves our best thinking, capabilities and technology. Let’s start exploring how our combined expertise can help you achieve your cell therapy ambitions.